Cargando…
Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare System
The traditional approach to the treatment of advanced non-small cell lung cancer (NSCLC) relied on the uniform use of cytotoxic chemotherapy. Over the last eight years, this paradigm of care has been shifting towards the use of molecularly targeted agents. Epidermal growth factor receptor (EGFR) mut...
Autores principales: | Dawe, David E., Ellis, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251366/ https://www.ncbi.nlm.nih.gov/pubmed/25562202 http://dx.doi.org/10.3390/jpm2030077 |
Ejemplares similares
-
Implementing systems medicine within healthcare
por: Kirschner, Marc, et al.
Publicado: (2015) -
Personalised medicine in the UK: challenges of implementation and impact on healthcare system
por: Pokorska-Bocci, Anna, et al.
Publicado: (2014) -
Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System
por: Dopazo, Joaquín, et al.
Publicado: (2021) -
N-of-1 Healthcare: Challenges and Prospects for the Future of Personalized Medicine
por: You, Kui, et al.
Publicado: (2022) -
Pharmacogenomic‐based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system
por: Subasri, Mathushan, et al.
Publicado: (2021)